Canaccord Adams reiterates a 'Buy' on Inverness Medical Innovations (NYSE: IMA), price target $47.

Canaccord analyst says, "Q4 was solid ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE